Colorectal Surgical Site Infection

Colorectal Surgical Site Infection: a Cohort Study About How Can we Decrease it

Surgical site infection (SSI) is one of the most common postoperative complications in surgery, with high morbidity. In the tertiary-center that the investigators evaluated they had a significant rate of surgical site infection. Because of that the investigators created a care bundle of measures in order to improve the outcomes.

Study Overview

• Status: Completed
• Conditions: Surgical Site Infection
• Intervention / Treatment: Procedure: Bundle of measures to decreased SSI

Detailed Description

Prospectively the investigators implemented a care bundle of measures with retrospective analysis, to decrease SSI . The superficial, deep and organ/space infections were evaluated and compared before and after care bundle implementation.

Between january 1, 2016 and December 31, 2020, 1139 patient records relating to surgical incisions were submitted for analysis.

• Study Type: Observational
• Enrollment (Actual): 1139

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients submitted to eletive colorectal surgery, by laparotomy, during a period of 5 years, in our colorectal department

Description

Inclusion Criteria:

• Patients submitted to elective colorectal surgery between 2016, january 1 and 2020, december 31
• Age > 18 years
• At least 30 days of follow-up

Exclusion Criteria:

• Patients submitted to urgent colorectal surgery

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The rate of surgical site infections	Evaluate the variation of surgical site infections during a period of 5 years	5 years

Collaborators and Investigators

• Sponsor: Centro Hospitalar Universitário Lisboa Norte

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2016
• Primary Completion (Actual): December 31, 2020
• Study Completion (Actual): July 31, 2021

Study Registration Dates

• First Submitted: April 11, 2022
• First Submitted That Met QC Criteria: April 26, 2022
• First Posted (Actual): May 2, 2022

Study Record Updates

• Last Update Posted (Actual): May 5, 2022
• Last Update Submitted That Met QC Criteria: April 29, 2022
• Last Verified: April 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Postoperative Complications; Disease Attributes; Wound Infection; Infections; Communicable Diseases; Surgical Wound Infection
• Other Study ID Numbers: 0003

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No